Abhishek Maiti, MBBS¹, Elias Jabbour, MD¹, Nitin Jain, MD², Gautam Borthakur, MD¹, Tapan M. Kadia, MD³, Jan A. Burger, MD, PhD¹, William G. Wierda, MD, PhD⁴, Marina Konopleva, MD, PhD⁵, Yesid Alvarado, MD⁶, Nicholas J. Short, MD¹, Stefan Faderl⁷, Susan M. O'Brien, MD⁸, Alessandra Ferrajoli, MD⁹, Steven M. Kornblau, MD¹⁰, Naval Daver, MD¹¹, Naveen Pemmaraju, MD¹, Prithviraj Bose, MD⁶, Philip A. Thompson, MB, MS¹², Joseph D. Khoury, MD¹³, Hayley Balkin^12*, Mary Kelly^14*, Hind Azzawi^15*, Rebecca Garris, MSc^1*, Guillermo Garcia-Manero, MD¹, Hagop M. Kantarjian, MD¹⁶ and Farhad Ravandi, MBBS¹⁷

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Associate Professor of Medicine Department of Leukemia The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁷John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁸UCI Cancer Center, Orange, CA
⁹Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
¹⁰Department of Stem Cell Transplantation, M.D. Anderson Cancer Center University of Texas, Houston, TX
¹¹Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
¹²The University of Texas MD Anderson Cancer Center, Houston, TX
¹³Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
¹⁵University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX
¹⁶University of Texas MD Anderson Cancer Center, Houston, TX
¹⁷Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

Fotini Vogiatzi, PhD^1*, Kristina Müller^1*, Dorothee Winterberg^2*, Thies Rösner, PhD^3*, Lennart Lenk, PhD^4*, Gunnar Cario, MD, PhD^5*, Martin Schrappe, MD PhD¹, Andreas E. Kulozik, MD, PhD^6*, Beat Bornhauser^7*, Jean-Pierre Bourquin, MD, PhD⁸, Thomas Valerius, MD³, Matthias Peipp, PhD^3*, Christian Kellner, PhD^9* and Denis Martin Schewe, MD^10*

¹Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany, Kiel, Germany
²Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany, Kiel, DEU
³Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany, Kiel, Germany
⁴UKSH Kiel, Kiel, Schleswig Holstein, Germany
⁵Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Schleswig-Holstein, Germany
⁶Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg and Hopp Children’s Cancer Center at Nationales Centrum for diseases Heidelberg, Heidelberg, Germany, Heidelberg, Germany
⁷Division of Pediatric Oncology, and Children Research Center, University Children´s Hospital, Zurich, Switzerland, Zurich, Switzerland
⁸Universitaets-Kinderspital Zurich, Zurich, Switzerland
⁹Division of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, LMU Munich, Munich, Germany, Munich, Germany
¹⁰Pediatric Hematology/Oncology, Kiel, Germany

Kimberly B. Johansson^1,2, Megan Gauthier, MD^2*, Feng Gao, MD, PhD, MPH^3* and Daniel C. Link, MD²

¹Medical Scientist Training Program, Washington University in St. Louis, St Louis, MO
²Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
³Washington University School of Medicine, Saint Louis, MO

Remko Schotte^1*, Julien Villaudy, PhD^1*, Greta De Jong, MD^1,2*, Viviana Neviani, PhD^3*, Wouter Pos, PhD^1*, Sophie E Levie^1*, Daniel M Go^1*, Etsuko Yasuda, PhD^1*, Esmay Frankin^1*, Madalina Cercel^1*, Susan E van Hal-van Veen^1*, Dorien van de Berg^1*, Anikó Szabó, MD^4*, Christien Fatmawati^1*, Martijn Kedde, PhD^1*, Yvonne Claassen^1*, Sjeng Horbach, PhD^5*, Anita W Rijneveld, MD, PhD^4*, Piet Gros, prof^6*, Hergen Spits, prof^1,7*, Mette D Hazenberg, MD, PhD^8,9* and Hans van Eenennaam, PhD^1*

¹AIMM Therapeutics, Amsterdam, Netherlands
²Department of Hematology, Academic Medical Center, Amsterdam Zuidoost, Netherlands
³Utrecht University, Utrecht, NLD
⁴Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands
⁵Sjeng Horbach Consultancy, Oss, Netherlands
⁶Utrecht University, Utrecht, Netherlands
⁷Amsterdam Infection and Immunity Institute (AI&II), Amsterdam, Netherlands
⁸Academic Medical Center, Amsterdam, Netherlands
⁹Department of Hematology, Amsterdam UMC, Academic Medical Center, Amsterdam, Netherlands

Kiyomi Morita, MD, PhD¹, Koji Sasaki, MD¹, Guillaume Richard-Carpentier, MD¹, Marina Konopleva, MD, PhD¹, Xuelin Huang, PhD^2*, Nicholas J. Short, MD¹, Nitin Jain, MD¹, Farhad Ravandi, MBBS³, Bouthaina S. Dabaja, MD^4*, Naval Daver, MD¹, Tapan M. Kadia, MD¹, Yesid Alvarado, MD⁵, Courtney D. DiNardo, MD, MSc⁶, Ghayas C. Issa, MD¹, Naveen Pemmaraju, MD¹, Guillermo Garcia-Manero, MD¹, Srdan Verstovsek, MD, PhD¹, Sa A Wang, MD^7*, Joseph D. Khoury, MD⁷, Jeffrey L. Jorgensen, MD, PhD^7*, Richard E. Champlin, MD⁸, Issa F. Khouri, MD⁸, Partow Kebriaei, MD⁸, Heather M. Schroeder^1*, Maria Khouri^1*, Koichi Takahashi, MD, PhD¹, Susan M. O'Brien, MD⁹, Hagop M. Kantarjian, MD¹⁰ and Elias Jabbour, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
⁴Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Division of Hematology/Oncology, Department of Medicine, UCI Health, Orange County
¹⁰Department of Leukemia, Professor and Chairman, Department of Leukemia, Samsung Distinguished University Chair in Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Paul Koller, MD¹, Karine Harutyunyan, PhD^2*, Antonio Cavazos, MSc^2*, Natalia Baran, PhD, MD³, Saradhi Mallampati, DVM, PhD^4*, Renee Chin^5*, Zhou Jiang, PhD^6*, Heng-Huan Lee, PhD^6*, Michael Curran, PhD^6*, Mien-Chie Hung, PhD^7* and Marina Konopleva, MD, PhD⁸

¹Department of Hematology/HCT, City of Hope, Duarte, CA
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁴Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston
⁵Graduate School of Biomedical Sciences, University of Texas Health Science Center Houston, Houston, TX
⁶University of Texas MD Anderson Cancer Center, Houston, TX
⁷China Medical University, Taichung, Taiwan
⁸Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX

Mark B. Geyer, MD^1,2, Amber C. King, PharmD, BCOP³, Justin C. O'Brien^1* and Jae H. Park, MD^2,4

¹Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Zhongbo Hu, MD, PhD¹, Michael Sporn, MD^2* and John Letterio, MD^3*

¹Rainbow Babies and Children's Hospital, Cleveland, OH
²Dartmouth Medical School, Hanover, NH
³Department of Pediatrics, Case Western Reserve University, Cleveland, OH

Sumit Gupta, MD¹, Nicole Mittman, PhD, MSc^2*, Petros Pechlivanoglou, M.Sc., PhD^3*, Qing Li, MSc^4*, Uma Athale, MD, MBBS, MSc⁵, Mylene Bassal, MD^6*, Vicky R. Breakey, BSc, MEd, FRCPC⁷, Paul J. Gibson, MD^8*, Mariana Silva, MD, FRCPC⁹, Veda Zabih^1*, Jason Pole, PhD^10* and Rinku Sutradhar, PhD^4,11,12*

¹Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada
²Canadian Agency for Drugs and Technologies in Health, Toronto, Canada
³Research Institute, Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada
⁴Cancer Research Program, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
⁵McMaster Children's Hospital, McMaster University, Division of Pediatric Hematology/Oncology, Hamilton, ON, Canada
⁶Children's Hospital of Eastern Ontario, Ottawa, ON, CAN
⁷McMaster Children's Hospital, Hamilton, ON, Canada
⁸Children's Hospital, London Health Sciences, London, ON, Canada
⁹Kingston General Hospital, Queen’s University, Kingston, ON, Canada
¹⁰Pediatric Oncology Group of Ontario, Toronto, ON, Canada
¹¹Institute for Health Policy, Evaluation and Management, University of Toronto, Toronto, ON, Canada
¹²Cancer Research Program, University of Toronto, Toronto, ON, Canada

Yousif Matloub, MD^1*, Lia Gore, MD², Mignon L. Loh, MD³, Chin-Hon Pui, MD⁴, Michael J. Hanley, PharmD, PhD^5*, Vickie Lu, PhD^5*, E. Jane Leonard, MSc^6*, Muriel Granier^7*, Andrea Biondi, MD⁸ and Lewis B. Silverman, MD⁹

¹Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, NJ
²Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado and Children’s Hospital, Aurora, CO
³University of California San Francisco, UCSF Medical Center-Mission Bay, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
⁴Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
⁵Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
⁶Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
⁷Incyte Biosciences Intl Sarl, Morges, Switzerland
⁸Clinica Pediatrica Universita Milano-Bicocca, Monza, Italy
⁹Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA